• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

适配体活性对相反末端延伸的依赖性:光调控效率的提高。

Dependence of aptamer activity on opposed terminal extensions: improvement of light-regulation efficiency.

机构信息

University of Frankfurt, Cluster of Excellence Macromolecular Complexes, Max-von-Laue-Str. 9, 60438 Frankfurt am Main, Germany.

出版信息

Nucleic Acids Res. 2010 Apr;38(6):2111-8. doi: 10.1093/nar/gkp1148. Epub 2009 Dec 8.

DOI:10.1093/nar/gkp1148
PMID:20007153
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2847219/
Abstract

Aptamers that can be regulated with light allow precise control of protein activity in space and time and hence of biological function in general. In a previous study, we showed that the activity of the thrombin-binding aptamer HD1 can be turned off by irradiation using a light activatable 'caged' intramolecular antisense-domain. However, the activity of the presented aptamer in its ON state was only mediocre. Here we studied the nature of this loss in activity in detail and found that switching from 5'- to 3'-extensions affords aptamers that are even more potent than the unmodified HD1. In particular we arrived at derivatives that are now more active than the aptamer NU172 that is currently in phase 2 clinical trials as an anticoagulant. As a result, we present light-regulatable aptamers with a superior activity in their ON state and an almost digital ON/OFF behavior upon irradiation.

摘要

适体可以通过光进行调控,从而实现蛋白质活性在空间和时间上的精确控制,进而控制生物功能。在之前的一项研究中,我们表明,凝血酶结合适体 HD1 的活性可以通过使用光激活的“笼状”分子内反义结构域的照射来关闭。然而,所呈现的适体在其开启状态下的活性仅为中等水平。在这里,我们详细研究了这种活性丧失的性质,发现从 5'-到 3'-延伸会提供比未修饰的 HD1 更有效的适体。特别是,我们得到了一些衍生物,它们的活性甚至比目前处于 2 期临床试验阶段的抗凝剂 NU172 适体更强。因此,我们提出了在开启状态下具有更高活性的光调控适体,并且在照射后几乎呈现出数字化的开启/关闭行为。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f048/2847219/e335b4950583/gkp1148f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f048/2847219/f88bd5f05ef0/gkp1148f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f048/2847219/490250e6372b/gkp1148f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f048/2847219/f209a306740e/gkp1148f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f048/2847219/f13d4660ea50/gkp1148f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f048/2847219/f9f07c93bf94/gkp1148f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f048/2847219/e335b4950583/gkp1148f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f048/2847219/f88bd5f05ef0/gkp1148f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f048/2847219/490250e6372b/gkp1148f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f048/2847219/f209a306740e/gkp1148f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f048/2847219/f13d4660ea50/gkp1148f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f048/2847219/f9f07c93bf94/gkp1148f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f048/2847219/e335b4950583/gkp1148f6.jpg

相似文献

1
Dependence of aptamer activity on opposed terminal extensions: improvement of light-regulation efficiency.适配体活性对相反末端延伸的依赖性:光调控效率的提高。
Nucleic Acids Res. 2010 Apr;38(6):2111-8. doi: 10.1093/nar/gkp1148. Epub 2009 Dec 8.
2
Cation Coordination Alters the Conformation of a Thrombin-Binding G-Quadruplex DNA Aptamer That Affects Inhibition of Thrombin.阳离子配位改变了影响凝血酶抑制的凝血酶结合G-四链体DNA适配体的构象。
Nucleic Acid Ther. 2016 Oct;26(5):299-308. doi: 10.1089/nat.2016.0606. Epub 2016 May 9.
3
Structure-Activity Relationship Study of a Potent α-Thrombin Binding Aptamer Incorporating Hexitol Nucleotides.一种含己糖醇核苷酸的强效 α-凝血酶结合适体的结构-活性关系研究。
Chemistry. 2020 Aug 3;26(43):9589-9597. doi: 10.1002/chem.202001504. Epub 2020 Jul 9.
4
Probing the Nitroindole-Modified Central Loop of Thrombin Aptamer HD1 as a Recognition Site.探究作为识别位点的凝血酶适体 HD1 中硝基吲哚修饰的中央环。
Nucleic Acid Ther. 2019 Aug;29(4):208-217. doi: 10.1089/nat.2018.0757. Epub 2019 Mar 13.
5
Several structural motifs cooperate in determining the highly effective anti-thrombin activity of NU172 aptamer.几种结构基序共同作用,决定了 NU172 适体的高效抗凝血酶活性。
Nucleic Acids Res. 2018 Dec 14;46(22):12177-12185. doi: 10.1093/nar/gky990.
6
Gold nanoparticles modified with self-assembled hybrid monolayer of triblock aptamers as a photoreversible anticoagulant.金纳米粒子经三嵌段适体自组装杂化单层修饰后作为光致可逆抗凝剂。
J Control Release. 2016 Jan 10;221:9-17. doi: 10.1016/j.jconrel.2015.11.028. Epub 2015 Nov 28.
7
Anticoagulant characteristics of HD1-22, a bivalent aptamer that specifically inhibits thrombin and prothrombinase.HD1-22的抗凝特性,一种特异性抑制凝血酶和凝血酶原酶的双价适体。
J Thromb Haemost. 2008 Dec;6(12):2105-12. doi: 10.1111/j.1538-7836.2008.03162.x. Epub 2008 Sep 27.
8
Increased anticoagulant activity of thrombin-binding DNA aptamers by nanoscale organization on DNA nanostructures.纳米结构上 DNA 纳米技术的组织化提高了凝血酶结合 DNA 适体的抗凝活性。
Nanomedicine. 2012 Jul;8(5):673-81. doi: 10.1016/j.nano.2011.08.011. Epub 2011 Sep 1.
9
Regulation of thrombin activity with a bifunctional aptamer and hemin: development of a new anticoagulant and antidote pair.用双功能适体和血红素调节凝血酶活性:新型抗凝剂和解药对的研发。
Chembiochem. 2009 Sep 4;10(13):2171-6. doi: 10.1002/cbic.200900408.
10
Thrombin binding aptamer, more than a simple aptamer: chemically modified derivatives and biomedical applications.凝血酶结合适体,不只是一个简单的适体:化学修饰衍生物及生物医学应用。
Curr Pharm Des. 2012;18(14):2036-47. doi: 10.2174/138161212799958387.

引用本文的文献

1
Manipulating DNA and RNA structures via click-to-release caged nucleic acids for biological and biomedical applications.通过点击释放型笼形核酸操纵DNA和RNA结构以用于生物学和生物医学应用。
Nucleic Acids Res. 2025 Jun 20;53(12). doi: 10.1093/nar/gkaf571.
2
Immune checkpoint inhibitors and cancer immunotherapy by aptamers: an overview.免疫检查点抑制剂和适体的癌症免疫治疗:概述。
Med Oncol. 2023 Dec 29;41(1):40. doi: 10.1007/s12032-023-02267-4.
3
Photocleavable -Nitrobenzyl-Protected DNA Architectures and Their Applications.光解硝基苄基保护的 DNA 结构及其应用。

本文引用的文献

1
Development of universal antidotes to control aptamer activity.开发通用解毒剂以控制适配体活性。
Nat Med. 2009 Oct;15(10):1224-8. doi: 10.1038/nm.1990. Epub 2009 Oct 4.
2
Using photons to manipulate enzyme inhibition by an azobenzene-modified nucleic acid probe.利用光子通过偶氮苯修饰的核酸探针来操纵酶抑制作用。
Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6489-94. doi: 10.1073/pnas.0812402106. Epub 2009 Apr 9.
3
The chemical biology of aptamers.适体的化学生物学
Chem Rev. 2023 May 24;123(10):6839-6887. doi: 10.1021/acs.chemrev.3c00016. Epub 2023 Apr 20.
4
Novel nanotherapeutics for cancer immunotherapy by CTLA-4 aptamer-functionalized albumin nanoparticle loaded with antihistamine.载有组胺拮抗剂的 CTLA-4 适体功能化白蛋白纳米颗粒用于癌症免疫治疗的新型纳米疗法。
J Cancer Res Clin Oncol. 2023 Aug;149(10):7515-7527. doi: 10.1007/s00432-023-04698-y. Epub 2023 Mar 26.
5
Expanding Catch and Release DNA Decoy (CRDD) Technology with Pyrimidine Mimics.嘧啶类似物拓展捕获与释放 DNA 诱饵(CRDD)技术。
Chemistry. 2022 Oct 18;28(58):e202201355. doi: 10.1002/chem.202201355. Epub 2022 Aug 25.
6
Controlling Coagulation in Blood with Red Light.用红光控制血液凝结。
Angew Chem Int Ed Engl. 2021 Oct 4;60(41):22441-22446. doi: 10.1002/anie.202108468. Epub 2021 Aug 31.
7
Scoring Functions for Protein-RNA Complex Structure Prediction: Advances, Applications, and Future Directions.蛋白质-核糖核酸复合物结构预测的评分函数:进展、应用及未来方向
Commun Inf Syst. 2020;20(1):1-22. doi: 10.4310/cis.2020.v20.n1.a1.
8
Covalent Bi-Modular Parallel and Antiparallel G-Quadruplex DNA Nanocostructs Reduce Viability of Patient Glioma Primary Cell Cultures.共价双模块平行和反平行 G-四链体 DNA 纳米结构降低患者神经胶质瘤原代细胞培养物的活力。
Int J Mol Sci. 2021 Mar 25;22(7):3372. doi: 10.3390/ijms22073372.
9
Application and development of aptamer in cancer: from clinical diagnosis to cancer therapy.适配体在癌症中的应用与发展:从临床诊断到癌症治疗
J Cancer. 2020 Oct 4;11(23):6902-6915. doi: 10.7150/jca.49532. eCollection 2020.
10
Design, Synthesis and Characterization of Cyclic NU172 Analogues: A Biophysical and Biological Insight.环状 NU172 类似物的设计、合成与表征:一种生物物理和生物学的深入研究。
Int J Mol Sci. 2020 May 29;21(11):3860. doi: 10.3390/ijms21113860.
Angew Chem Int Ed Engl. 2009;48(15):2672-89. doi: 10.1002/anie.200804643.
4
Differential regulation of protein subdomain activity with caged bivalent ligands.笼形二价配体对蛋白质亚结构域活性的差异调节。
Chembiochem. 2009 Mar 2;10(4):654-7. doi: 10.1002/cbic.200800814.
5
Crystal structure of an RNA aptamer bound to thrombin.与凝血酶结合的RNA适配体的晶体结构。
RNA. 2008 Dec;14(12):2504-12. doi: 10.1261/rna.1239308. Epub 2008 Oct 29.
6
Anticoagulant characteristics of HD1-22, a bivalent aptamer that specifically inhibits thrombin and prothrombinase.HD1-22的抗凝特性,一种特异性抑制凝血酶和凝血酶原酶的双价适体。
J Thromb Haemost. 2008 Dec;6(12):2105-12. doi: 10.1111/j.1538-7836.2008.03162.x. Epub 2008 Sep 27.
7
Pegaptanib sodium for the treatment of age-related macular degeneration.聚乙二醇化重组人血管内皮生长因子受体1拮抗剂钠用于治疗年龄相关性黄斑变性。
Expert Opin Pharmacother. 2008 Feb;9(3):499-508. doi: 10.1517/14656566.9.3.499.
8
Multidomain targeting generates a high-affinity thrombin-inhibiting bivalent aptamer.多结构域靶向产生一种高亲和力的凝血酶抑制性二价适体。
Chembiochem. 2007 Dec 17;8(18):2223-6. doi: 10.1002/cbic.200700535.
9
Light-dependent RNA interference with nucleobase-caged siRNAs.基于光控的核碱基笼化小干扰RNA介导的RNA干扰
RNA. 2007 Dec;13(12):2341-7. doi: 10.1261/rna.753407. Epub 2007 Oct 19.
10
Functional aptamers and aptazymes in biotechnology, diagnostics, and therapy.生物技术、诊断和治疗中的功能性适体与核酸酶。
Chem Rev. 2007 Sep;107(9):3715-43. doi: 10.1021/cr0306743. Epub 2007 Aug 23.